A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
Public ClinicalTrials.gov record NCT02391480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer
Study identification
- NCT ID
- NCT02391480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Interventions
- ABBV-075 Drug
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2015
- Primary completion
- Jul 4, 2019
- Completion
- Jul 4, 2019
- Last update posted
- Nov 28, 2019
2015 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Healthcare /ID# 132963 | Scottsdale | Arizona | 85258-4566 | — |
| City of Hope /ID# 154053 | Duarte | California | 91010 | — |
| UC Davis Comp Cancer Ctr /ID# 154644 | Sacramento | California | 95817 | — |
| Yale University /ID# 136982 | New Haven | Connecticut | 06510 | — |
| University of Chicago /ID# 155453 | Chicago | Illinois | 60637-1443 | — |
| Indiana Univ School Medicine /ID# 132946 | Indianapolis | Indiana | 46202 | — |
| Duke Univ Med Ctr /ID# 154647 | Durham | North Carolina | 27705 | — |
| Mary Crowley Cancer Research /ID# 154059 | Dallas | Texas | 75230 | — |
| Univ TX, MD Anderson /ID# 132276 | Houston | Texas | 77030 | — |
| UT MD Anderson Cancer Center /ID# 164122 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02391480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2019 · Synced Apr 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02391480 live on ClinicalTrials.gov.